(IPE) Ipopema Securities - Ratings and Ratios

Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLIPOPM00011

IPE: Investment, Banking, Brokerage, Funds, Securities, Advisory

IPOPEMA Securities S.A., established in 2005 and headquartered in Warsaw, Poland, is a prominent financial services firm specializing in brokerage, equity research, and investment banking. The company operates through three primary segments: Brokerage and Related Services, Investment Fund and Portfolio Management, and Consulting Services. The Brokerage segment offers investment advisory services, corporate financial restructuring, and infrastructure project financing. The Investment Fund segment manages closed-end and open-end funds, while the Consulting segment provides business and IT advisory services. Additionally, the firm excels in investment banking, facilitating equity transactions, M&A, and share repurchase programs. Their services also include securities trading, investment product distribution, and IT solutions.

With a strong market presence in Warsaw, IPOPEMA Securities is known for its expertise in navigating Polands financial landscape. Their comprehensive services cater to both individual and institutional clients, supported by a team of seasoned professionals. The companys commitment to innovation and client-centric solutions has solidified its reputation in the industry.

3-Month Forecast: - Technical Outlook: - The stock price (IPE) is anticipated to oscillate between support at SMA 50 (2.78) and resistance at SMA 200 (2.98). - With an ATR of 0.09, volatility is expected to remain subdued, suggesting price movements within a narrow range. - Fundamental Outlook: - The companys low P/E (5.71) and P/B (0.73) ratios indicate potential undervaluation, which may attract value investors. - However, the absence of a forward P/E figure introduces uncertainty, reflecting limited analyst visibility. - Market participants may remain cautious, balancing the attractive valuations against the lack of growth visibility. - Price Target: - The stock is projected to trade within a range of 2.80 to 3.10 PLN over the next three months, driven by its current valuation and technical indicators.

Additional Sources for IPE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

IPE Stock Overview

Market Cap in USD 23m
Sector Financial Services
Industry Capital Markets
GiC Sub-Industry Investment Banking & Brokerage
IPO / Inception

IPE Stock Ratings

Growth 5y 22.3%
Fundamental 26.7%
Dividend 31.7%
Rel. Strength -16.9
Analysts -
Fair Price Momentum 2.84 PLN
Fair Price DCF 35.03 PLN

IPE Dividends

Dividend Yield 12m 10.20%
Yield on Cost 5y 26.32%
Annual Growth 5y -5.11%
Payout Consistency 39.2%

IPE Growth Ratios

Growth Correlation 3m 75.2%
Growth Correlation 12m -66%
Growth Correlation 5y 14.9%
CAGR 5y 20.68%
CAGR/Max DD 5y 0.32
Sharpe Ratio 12m -0.12
Alpha -12.92
Beta 1.079
Volatility 83.14%
Current Volume 9.6k
Average Volume 20d 4k
What is the price of IPE stocks?
As of April 06, 2025, the stock is trading at PLN 2.86 with a total of 9,605 shares traded.
Over the past week, the price has changed by -13.33%, over one month by -3.05%, over three months by +4.76% and over the past year by -9.43%.
Is Ipopema Securities a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Ipopema Securities is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.71 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IPE as of April 2025 is 2.84. This means that IPE is currently overvalued and has a potential downside of -0.7%.
Is IPE a buy, sell or hold?
Ipopema Securities has no consensus analysts rating.
What are the forecast for IPE stock price target?
According to ValueRays Forecast Model, IPE Ipopema Securities will be worth about 3.2 in April 2026. The stock is currently trading at 2.86. This means that the stock has a potential upside of +10.84%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 3.2 10.8%